Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$0.90 - $3.45
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Last Price
Market Cap | $55.36M |
EV | $172.59M |
Shares Outstanding | 36.18M |
Beta | 0.92 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $7.00 |
P/E 2025E | - |
P/Revenue 2025E | 10.07x |
Revenue | 5.00% |
EPS | 18.50% |
Operating Cash Flow | -16.80% |
Free Cash Flow | -10.60% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 100.00% |
Net Profit Margin 2025E | -1296.36% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Armata Pharmaceuticals, Inc.
ARMP
Sector
Healthcare
Industry
Biotechnology
CEO
Birx, Deborah
Employees
60
Website
www.armatapharma.comIPO Date
1994-05-20
Headquarters
5005 McConnell Avenue, Los Angeles, California, 90066, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved